Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $143.70, for a total transaction of $215,550.00. Following the completion of the sale, the chief executive officer directly owned 69,214 shares of the company’s stock, valued at $9,946,051.80. The trade was a 2.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Plexus Stock Down 1.4%
PLXS stock opened at $145.16 on Friday. The stock has a market capitalization of $3.92 billion, a P/E ratio of 24.73 and a beta of 0.80. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. Plexus Corp. has a one year low of $103.43 and a one year high of $172.89. The company has a 50 day moving average price of $136.05 and a two-hundred day moving average price of $131.67.
Plexus (NASDAQ:PLXS – Get Free Report) last released its earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Plexus had a net margin of 4.04% and a return on equity of 12.33%. Plexus’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.45 EPS. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, sell-side analysts expect that Plexus Corp. will post 5.9 EPS for the current year.
Hedge Funds Weigh In On Plexus
Analysts Set New Price Targets
Several analysts have commented on PLXS shares. Needham & Company LLC lowered their target price on shares of Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a research note on Thursday, July 24th. Williams Trading set a $165.00 price objective on shares of Plexus in a research note on Monday, September 22nd. Wall Street Zen cut shares of Plexus from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 16th. Benchmark boosted their price objective on shares of Plexus from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, September 22nd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a research note on Saturday, September 27th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $155.60.
Read Our Latest Stock Report on Plexus
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories
- Five stocks we like better than Plexus
- What Investors Need to Know to Beat the Market
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- 3 REITs to Buy and Hold for the Long Term
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Roth IRA Calculator: Calculate Your Potential Returns
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
